FDA Fast Track Designation Granted to 4D Molecular Therapeutics 4D-125 for the Treatment of X-linked Retinitis Pigmentosa

https://www.globenewswire.com/news-release/2022/01/10/2363994/0/en/4D-Molecular-Therapeutics-Announces-FDA-Fast-Track-Designation-Granted-to-4D-125-for-the-Treatment-of-X-linked-Retinitis-Pigmentosa.html